[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353553-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353553-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pten-deletions-are-associated-with-tumor-progression-but-unrelated-to-patient-prognosis-in-muscle-invasive-urothelial-bladder-carcinomas-a-large-multi-center-validation-study","PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas - A Large Multi-Center Validation Study","","The tumor suppressor gene PTEN is a key regulator across cancer types through mechanisms including gene mutations and deletions. In a large multi-center validation study, PTEN copy-number changes were assessed by fluorescence in situ hybridization (FISH) in more than 2700 muscle-invasive urothelial bladder carcinomas and compared with clinicopathological features, p53/p16 alterations, and prior cohort outcomes. PTEN deletions occurred in 18.8% of analyzable tumors, rose with grade progression, and correlated with p53 alterations and p16 overexpression, but showed no prognostic association in pT2–4 disease.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pten-deletions-are-associated-with-tumor-progression-but-unrelated-to-patient-prognosis-in-muscle-invasive-urothelial-bladder-carcinomas-a-large-multi-center-validation-study/353553/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pten-deletions-are-associated-with-tumor-progression-but-unrelated-to-patient-prognosis-in-muscle-invasive-urothelial-bladder-carcinomas-a-large-multi-center-validation-study/353553.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the PTEN deletions study?","Question",{"text":63,"@type":64},"To determine how PTEN deletions relate to tumor aggressiveness, patient prognosis, and p53/p16 alterations in muscle-invasive urothelial bladder carcinomas, expanding earlier findings.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PTEN deletions measured and in how many tumors?",{"text":68,"@type":64},"PTEN copy-number status was analyzed by FISH on a tissue microarray format containing more than 2700 urothelial bladder carcinomas.",{"name":70,"@type":61,"acceptedAnswer":71},"Do PTEN deletions predict patient prognosis in pT2–4 urothelial bladder cancers?",{"text":72,"@type":64},"No. In pT2–4 cancers, PTEN deletions were unrelated to histopathological parameters of tumor aggressiveness and patient outcome.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353553,1790193021,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Genes, Chromosomes and Cancer   \n RESEARCH ARTICLE  OPEN ACCESS   \nPTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas  \nMartina Kluth1  | Henning Plage2  | Kira Furlano2 | Sebastian Hofbauer2 | Sarah Weinberger2 | Annika Fendler2 | Bernhard Ralla2 | Simon Schallenberg3 | Sefer Elezkurtaj3 | Maximilian Lennartz1  | Andreas H. Marx4 |  \nHenrik Samtleben4 | Margit Fisch5 | Michael Rink6 | Marcin Slojewski7 | Krystian Kaczmarek7 | Thorsten Ecke8 |  \nNico Adamini9 | Joachim Weischenfeldt2,10,11 | Henrik Zecha2,9 | Ronald Simon1  | Guido Sauter1 | Thorsten Schlomm2 | David Horst3 | Sarah Minner1   \n1Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany | 2Department of Urology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany | 3Institute of Pathology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany | 4Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany | 5Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany | 6Department of Urology, Marienhospital Hamburg, Hamburg, Germany | 7Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland | 8Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany | 9Department of Urology, Albertinen Hospital, Hamburg, Germany | 10Biotech Research & Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark | 11Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark  \nCorrespondence: Martina Kluth ([m.kluth@uke.de](m.kluth@uke.de))  \nReceived: 28 August 2025 | Revised: 14 December 2025 | Accepted: 16 December 2025  \nKeywords: FISH | muscle-invasive | prognosis | PTEN deletions | tissue microarray | urothelial bladder cancer  \nABSTRACT  \nThe tumor suppressor gene PTEN plays an important role in many cancer types. Mechanism of PTEN inactivation includes gene mutations and deletions. In this large multi-center study, we analyzed the impact of PTEN deletions on tumor aggressiveness, patient prognosis, and p53 and p16 alterations, especially in muscle-invasive urothelial bladder carcinomas to expand the results from our previous study on 686 pTa to pT4 urothelial bladder carcinomas. The PTEN copy number status was analyzed by fluorescence in situ hybridization (FISH) on more than 2700 urothelial bladder carcinomas in a tissue microarray format. PTEN deletion data were compared with clinico-pathological parameters in pTa and pT2-4 carcinomas and clinical outcomes in pT2-4 carcinomas, immunohistochemical p16 and p53 expression, and TP53 copy number status measured by FISH from previous studies. PTEN deletions occurred in 18.8% of 1854 analyzable carcinomas, including 17.6% heterozygous and 1.2% homozygous deleted tumors. The PTEN deletion rate increased markedly from pTaG2 low-grade (3.1%), to pTaG2 high-grade (4.5%) and pTaG3 (20.7%, p\u003C 0.0001) carcinomas, and was 23.8% in pT2-4 carcinomas (p \u003C 0.0001 for pTa vs. pT2-4). In pT2-4 cancers, PTEN deletions were unrelated to histopathological parameters of tumor aggressiveness and patient outcome. PTEN deletions were significantly associated with parameters of p53 alterations and p16 overexpression. It is concluded that PTEN deletions accumulate with grade progression in non-invasive urothelial carcinomas ofthe urinary bladder. The absence of a prognostic role of PTEN deletions in pT2-4 urothelial carcinomas is in line with our notorious inability to predict the clinical course of these tumors by only one morphological or molecular feature.  \n\n| Abbreviations: CGH, comparative genomic hybridization; FISH, fluorescence in situ hybridization;","cbCaigX6K3q3jjsJ","https://ap.wps.com/l/cbCaigX6K3q3jjsJ","pdf",2398215,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main objective of the PTEN deletions study?\",\"answer\":\"To determine how PTEN deletions relate to tumor aggressiveness, patient prognosis, and p53/p16 alterations in muscle-invasive urothelial bladder carcinomas, expanding earlier findings.\"},{\"question\":\"How were PTEN deletions measured and in how many tumors?\",\"answer\":\"PTEN copy-number status was analyzed by FISH on a tissue microarray format containing more than 2700 urothelial bladder carcinomas.\"},{\"question\":\"Do PTEN deletions predict patient prognosis in pT2–4 urothelial bladder cancers?\",\"answer\":\"No. In pT2–4 cancers, PTEN deletions were unrelated to histopathological parameters of tumor aggressiveness and patient outcome.\"}]","PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas - A Large Multi-Center Validation Study | PDF",1790106016,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22826bc1ce58c2d486195ad386d59347.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2d742df9125709348f7dead4c199d89.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/beaa67d4595df0a860d0cc55573ad6af.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98262580a76d2a724737ee3c6d1ed78e.webp",980,1287]